Upadacitinib for Treatment of Granulomatous Cheilitis
Axel De Greef, C. Peeters, Olivier Dewit, Laurence de Montjoye, Marie Baeck
Abstract
This case series examines the effectiveness of the Janus kinase inhibitor upadacitinib for the treatment of granulomatous cheilitis.
Topics & Concepts
MedicineDermatologyJanus kinaseJanus kinase inhibitorInternal medicineReceptorAutoimmune and Inflammatory DisordersHidradenitis Suppurativa and TreatmentsAutoimmune Bullous Skin Diseases